Sean Pitroda, M.D.

Citace

	Všechny	Od 2020
Citace	5077	3562
h-index	39	33
i10-index	65	59

840

420

210

630

2009201020112012201320142015201620172018201920202021202220232024202519 55 83 74 95 104 132 157 204 195 373 529 639 672 756 821 142

Veřejný přístup

Zobrazit všechny

48 článků

0 článků

dostupné

nedostupné

Vychází ze zplnomocnění pro financování

Spoluautoři

ralph weichselbaumprofessor radiation oncology university of chicagoE-mailová adresa ověřena na: radonc.uchicago.edu
Steven J Chmura MD, PhDUniversity of ChicagoE-mailová adresa ověřena na: radonc.uchicago.edu
Jason John LukeUPMC / Univ. of PittsburghE-mailová adresa ověřena na: upmc.edu
Rohan KatipallyDepartment of Radiation and Cellular Oncology, University of ChicagoE-mailová adresa ověřena na: uchospitals.edu
Stanley L LiauwUniversity of ChicagoE-mailová adresa ověřena na: uchicago.edu
Philip P. ConnellProfessor of Radiation Oncology, University of ChicagoE-mailová adresa ověřena na: radonc.uchicago.edu
Hua LiangUniversity of ChicagoE-mailová adresa ověřena na: uchicago.edu
Sean C Wightman, MD, FACSAssociate Professor of Clinical Surgery, Keck School of Medicine, University of Southern CaliforniaE-mailová adresa ověřena na: med.usc.edu
Liam F. Spurr, MDUniversity of ChicagoE-mailová adresa ověřena na: uchicagomedicine.org
Thomas F GajewskiProfessor, University of ChicagoE-mailová adresa ověřena na: medicine.bsd.uchicago.edu
Carlos A MartinezUniversity of ChicagoE-mailová adresa ověřena na: uchicago.edu
Sajid KhanYale UniversityE-mailová adresa ověřena na: yale.edu
Kaiting YangSouth China University of TechnologyE-mailová adresa ověřena na: scut.edu.cn
Yuzhu HouXI'AN Jiaotong UniversityE-mailová adresa ověřena na: xjtu.edu.cn
Akash ParekhAssistant Professor, Boston UniversityE-mailová adresa ověřena na: bmc.org
Ravi F. Sood, M.D., M.S.University of California DavisE-mailová adresa ověřena na: ucdavis.edu
Yang-Xin FuTsinghua UniversityE-mailová adresa ověřena na: tsinghua.edu.cn
Bernard RoizmanProfessor of Virology University of ChicagoE-mailová adresa ověřena na: bsd.uchicago.edu
Joseph K Salama, MD, FASTROProfessor of Radiation Oncology, Duke University School of MedicineE-mailová adresa ověřena na: duke.edu
Sabah Kadri, PhDAbbVieE-mailová adresa ověřena na: abbvie.com

Sledovat

Sean Pitroda, M.D.

The University of Chicago

E-mailová adresa ověřena na: uchicago.edu - Domovská stránka

cancer biology biomarkers radiation oncology immunotherapy bioinformatics


Název Seřadit podle citací Seřadit podle roku Seřadit podle názvu	Citace Citace	Rok
Safety and clinical activity of pembrolizumab and multisite stereotactic body radiotherapy in patients with advanced solid tumors JJ Luke, JM Lemons, TG Karrison, SP Pitroda, JM Melotek, Y Zha, ... Journal of Clinical Oncology 36 (16), 1611-1618, 2018	558	2018
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis SP Pitroda, NN Khodarev, L Huang, A Uppal, SC Wightman, S Ganai, ... Nature communications 9 (1), 1793, 2018	246	2018
Tumor-reprogrammed resident T cells resist radiation to control tumors A Arina, M Beckett, C Fernandez, W Zheng, S Pitroda, SJ Chmura, ... Nature communications 10 (1), 3959, 2019	206	2019
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs DRE Ranoa, AD Parekh, SP Pitroda, X Huang, T Darga, AC Wong, ... Oncotarget 7 (18), 26496, 2016	191	2016
STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect SP Pitroda, BT Wakim, RF Sood, MG Beveridge, MA Beckett, ... BMC medicine 7, 1-10, 2009	189	2009
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer NN Khodarev, SP Pitroda, MA Beckett, DM MacDermed, L Huang, ... Cancer research 69 (7), 2833-2837, 2009	146	2009
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome SC Wightman, A Uppal, SP Pitroda, S Ganai, B Burnette, M Stack, ... British journal of cancer 113 (2), 327-335, 2015	140	2015
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy NN Khodarev, P Roach, SP Pitroda, DW Golden, M Bhayani, MY Shao, ... PloS one 4 (6), e5821, 2009	140	2009
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer Y Yasumizu, H Rajabi, C Jin, T Hata, S Pitroda, MD Long, M Hagiwara, ... Nature communications 11 (1), 338, 2020	134	2020
Clinical and molecular markers of long‐term survival after oligometastasis‐directed stereotactic body radiotherapy (SBRT) AC Wong, SP Watson, SP Pitroda, CH Son, LC Das, ME Stack, A Uppal, ... Cancer 122 (14), 2242-2250, 2016	131	2016
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment SP Pitroda, NN Khodarev, MA Beckett, DW Kufe, RR Weichselbaum Proceedings of the National Academy of Sciences 106 (14), 5837-5841, 2009	131	2009
Integration of radiotherapy and immunotherapy for treatment of oligometastases SP Pitroda, SJ Chmura, RR Weichselbaum The Lancet Oncology 20 (8), e434-e442, 2019	129	2019
14q32-encoded microRNAs mediate an oligometastatic phenotype A Uppal, SC Wightman, S Mallon, G Oshima, SP Pitroda, Q Zhang, ... Oncotarget 6 (6), 3540, 2015	120	2015
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer N Khodarev, R Ahmad, H Rajabi, S Pitroda, T Kufe, C McClary, MD Joshi, ... Oncogene 29 (6), 920-929, 2010	118	2010
Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging SL Liauw, SP Pitroda, SE Eggener, WM Stadler, CA Pelizzari, ... International Journal of Radiation Oncology* Biology* Physics 85 (2), 378-384, 2013	111	2013
DNA repair pathway gene expression score correlates with repair proficiency and tumor sensitivity to chemotherapy SP Pitroda, IM Pashtan, HL Logan, B Budke, TE Darga, ... Science translational medicine 6 (229), 229ra42-229ra42, 2014	107	2014
Oligometastatic prostate cancer: reality or figment of imagination? CC Foster, RR Weichselbaum, SP Pitroda Cancer 125 (3), 340-352, 2019	99	2019
MUC1-C activates the TAK1 inflammatory pathway in colon cancer H Takahashi, C Jin, H Rajabi, S Pitroda, M Alam, R Ahmad, D Raina, ... Oncogene 34 (40), 5187-5197, 2015	99	2015
Radiotherapy and immunotherapy: open questions and future strategies KB Pointer, SP Pitroda, RR Weichselbaum Trends in cancer 8 (1), 9-20, 2022	97	2022
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy L Wang, X Dou, S Chen, X Yu, X Huang, L Zhang, Y Chen, J Wang, ... Cancer Cell 41 (7), 1294-1308. e8, 2023	95	2023

Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.

Články 1–20

Citace za rok

Duplicitní citace

Sloučené citace

Přidat spoluautorySpoluautoři

Sledovat

Citace

Spoluautoři